Cite
Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status.
MLA
Wu, Qiong, et al. “Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status.” International Journal of Molecular Sciences, vol. 24, no. 20, Oct. 2023, p. 15179. EBSCOhost, https://doi.org/10.3390/ijms242015179.
APA
Wu, Q., Berglund, A. E., Macaulay, R. J., & Etame, A. B. (2023). Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status. International Journal of Molecular Sciences, 24(20), 15179. https://doi.org/10.3390/ijms242015179
Chicago
Wu, Qiong, Anders E. Berglund, Robert J. Macaulay, and Arnold B. Etame. 2023. “Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status.” International Journal of Molecular Sciences 24 (20): 15179. doi:10.3390/ijms242015179.